154 related articles for article (PubMed ID: 2412005)
1. Pharmacological basis of the antihypertensive action of calcium entry blockers.
van Zwieten PA; Timmermans PB
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S11-7. PubMed ID: 2412005
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
[TBL] [Abstract][Full Text] [Related]
3. Vascular aspects of calcium antagonists.
Van Zwieten PA; Van Meel JC; Timmermans PB
Pharm Weekbl Sci; 1981 Dec; 3(6):237-47. PubMed ID: 6120500
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Hypertension; 1983; 5(4 Pt 2):II8-17. PubMed ID: 6134673
[TBL] [Abstract][Full Text] [Related]
5. Calcium-entry blockers, vascular smooth muscle and systemic hypertension.
Vanhoutte PM
Am J Cardiol; 1985 Jan; 55(3):17B-23B. PubMed ID: 3881910
[TBL] [Abstract][Full Text] [Related]
6. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
7. [Interaction between calcium inhibitors and vascular alpha-adrenergic receptors].
van Zwieten PA; Timmermans PB
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():7-13. PubMed ID: 3004370
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy. Concepts and new agents.
Frohlich ED
Postgrad Med; 1985 May; 77(6):122-6, 133-6. PubMed ID: 2859582
[TBL] [Abstract][Full Text] [Related]
9. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Busse R; Bassenge E
Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
[TBL] [Abstract][Full Text] [Related]
10. [Calcium antagonists, diuretics, beta-blockers and alpha-blockers].
Hasegawa J
Nihon Rinsho; 2012 Aug; 70 Suppl 6():245-52. PubMed ID: 23156516
[No Abstract] [Full Text] [Related]
11. Pharmacological basis for use of calcium channel antagonists in hypertension.
Scriabine A; Kazda S; Garthoff B; Nickerson PA
Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of calcium entry blockers into calcium channel blockers and calcium overload blockers.
van Zwieten PA
Eur Neurol; 1986; 25 Suppl 1():57-67. PubMed ID: 3758108
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the inhibitory activities of calcium entry blockers on vascular smooth muscle constriction in vitro after K+-depolarisation and in vivo after alpha 2-adrenoceptor stimulation.
van Meel JC; Towart R; Kazda S; Timmermans PB; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):34-7. PubMed ID: 6302522
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.
Van Meel JC; Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1983 Aug; 92(1-2):27-34. PubMed ID: 6313390
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological basis of antihypertensive drug therapy].
Kolck UW; Zaugg CE; Erne P
Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and arterial anticalcinotic effects of calcium antagonists.
Fleckenstein A; Frey M; Fleckenstein-Grün G
Am J Cardiol; 1986 Feb; 57(7):1D-10D. PubMed ID: 3513510
[TBL] [Abstract][Full Text] [Related]
17. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
van Meel JC; Timmermans PB; van Zwieten PA
J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
[TBL] [Abstract][Full Text] [Related]
18. Calcium antagonists--terminology, classification and comparison.
van Zwieten PA
Arzneimittelforschung; 1985; 35(1A):298-301. PubMed ID: 4039169
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive drugs.
Laurent S
Pharmacol Res; 2017 Oct; 124():116-125. PubMed ID: 28780421
[TBL] [Abstract][Full Text] [Related]
20. Different vasodilating mechanisms--different peripheral effects?
Breckenridge A; Roberts D; Walley T
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S23-6. PubMed ID: 1378145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
